Associations of high STING levels with unfavorable tumor features were found in carcinomas of the cervix uteri [17], ovary [18], stomach [19], colon [20], lung [21], larynx [22] tongue [16], and kidney [23], while low STING levels were related to unfavorable tumor features in carcinomas of the breast [24], head and neck [25], the urinary tract [26], lung [27,28], and stomach [15], as well as in T-cell lymphoma [29]. The gene discussed is STING1; the disease is breast carcinoma.